Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)
-
By
-
Rohan R Kasthuri
-
Harish Eswaran
-
Karen Smith
-
Raj S Kasthuri
-
February 3, 2026
-
Objective:
To provide an overview of hereditary hemorrhagic telangiectasia (HHT), including its causes, symptoms, diagnosis, and management.
Key Findings:
- HHT is underrecognized and often diagnosed late.
- 90% of patients experience recurrent nosebleeds.
- AVMs can lead to serious complications, including stroke and heart failure.
Interpretation:
Early diagnosis and management of HHT are crucial to prevent severe complications associated with AVMs.
Limitations:
- HHT is frequently underdiagnosed due to lack of awareness.
- Symptoms may not appear until later in life, complicating early detection.
Conclusion:
Understanding HHT is vital for timely diagnosis and management to mitigate risks associated with the disorder.
